The suspense surrounding Lil Durk’s federal trial intensified Thursday after jurors completed their second day of deliberations without reaching a verdict, extending the anxious wait over the Chicago rapper’s fate.

Lil Durk, whose legal name is Durk Banks, is standing trial alongside co-defendants Deandre Wilson and David Lindsey in federal court in Los Angeles. The jury began deliberating on September 9 following closing arguments in the closely watched case.

After two days of discussions, however, jurors have yet to announce a decision.

The lengthy deliberations come as the panel carefully examines multiple federal counts connected to an alleged plot targeting rapper Quando Rondo, whose real name is Tyquian Bowman. Prosecutors allege that Durk financed and directed an operation intended to kill Rondo in Los Angeles in August 2022. The shooting instead resulted in the death of Rondo’s cousin, Saviay’a “Lul Pab” Robinson.

During deliberations, the jury has demonstrated that it is closely studying the case. On the first day, jurors requested access to trial evidence in digital form, leading the court to arrange for the materials to be provided electronically.

On Day 2, jurors also sought clarification on jury instructions involving the alleged agreement to stalk Quando Rondo and the meaning of “intent” in an instruction connected to the stalking count involving Lul Pab’s death.

Despite growing speculation surrounding the length of deliberations, two days without a verdict does not necessarily mean the jury is deadlocked or leaning toward either conviction or acquittal. The panel must consider multiple charges, multiple defendants and weeks of evidence before reaching unanimous decisions on the counts before it.

For Lil Durk and his supporters, the waiting game now continues.

The rapper remains presumed innocent unless and until prosecutors convince the jury of his guilt beyond a reasonable doubt.

With Day 2 ending without a verdict, attention now turns to the next round of deliberations as one of hip-hop’s most closely followed federal trials moves closer to a potentially dramatic conclusion.